BioSpace News Archive

Marinus Pharmaceuticals, Inc., a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, announced the grant of inducement awards to three new employees.

Adaptive Research Inc., an integrated clinical trial site organization with a unique purpose to democratize clinical trials by integrating community physicians into the clinical trial process, today announced that American Molecular Imaging has joined the Adaptive Research network to generate greater access to clinical trials and provide a path to market for groundbreaking medical products.

CS Genetics, a privately held genomics-technology company, announced the appointment of Jay Harger, PhD, as Senior Vice President of Operations.

MorphoSys U.S. Inc. announced that the National Comprehensive Cancer Network Clinical Practice Guidelines ) in Oncology for B-cell Lymphomas have been updated, and the designation for Monjuvi in combination with lenalidomide is now a Preferred Regimen for second-line therapy in patients with Diffuse Large B-cell Lymphoma who are not candidates for transplant.

Catalyst Biosciences, Inc. (NASDAQ: CBIO) today announced that the company has regained full rights to CB 2782-PEG, a C3-degrader for the treatment of dry AMD (dAMD).

Champions Oncology, Inc., a leading global technology-enabled biotech that is transforming drug discovery through innovative AI-driven pharmaco-pheno-multiomic integration, announced its financial results for its third quarter of fiscal 2022, ended January 31, 2022.

Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), today reported financial results for the full year ended December 31, 2021 and summarized recent business highlights.

Inozyme Pharma, Inc. reported financial results for the full year ended December 31, 2021, and provided recent business highlights.

Anika Therapeutics, Inc., a global joint preservation company in early intervention orthopedics, announced that it granted.

Emergence of gene therapies altered the way many diseases and conditions were treated. Researchers, scientists, and experts have been developing new therapies by engineering genes and treating various conditions.